News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
81,035 Results
Type
Article (16176)
Company Profile (43)
Press Release (64804)
Multimedia
Podcasts (54)
Webinars (10)
Section
Business (25697)
Career Advice (896)
Deals (4514)
Drug Delivery (35)
Drug Development (8304)
Employer Resources (67)
FDA (1119)
Job Trends (2117)
News (39105)
Policy (2768)
Tag
Academia (258)
Accelerated approval (6)
Adcomms (15)
Allergies (13)
Alliances (7241)
ALS (37)
Alzheimer's disease (211)
Antibody-drug conjugate (ADC) (100)
Approvals (1035)
Artificial intelligence (136)
Autoimmune disease (32)
Automation (6)
Bankruptcy (58)
Best Places to Work (893)
BIOSECURE Act (17)
Biosimilars (41)
Biotechnology (36)
Bladder cancer (32)
Brain cancer (16)
Breast cancer (58)
Cancer (746)
Cardiovascular disease (91)
Career advice (731)
Career pathing (21)
CAR-T (80)
CDC (5)
Cell therapy (215)
Cervical cancer (5)
Clinical research (6626)
Collaboration (435)
Company closure (3)
Compensation (13)
Complete response letters (26)
COVID-19 (432)
CRISPR (22)
C-suite (265)
Cystic fibrosis (19)
Data (585)
Denatured (9)
Depression (37)
Diabetes (39)
Diagnostics (530)
Digital health (5)
Diversity (3)
Diversity, equity & inclusion (19)
Drug discovery (60)
Drug pricing (37)
Duchenne muscular dystrophy (60)
Earnings (5175)
Editorial (25)
Employer branding (8)
Employer resources (67)
Events (10972)
Executive appointments (308)
FDA (1386)
Friedreich's ataxia (3)
Frontotemporal dementia (5)
Funding (404)
Gene editing (58)
Generative AI (14)
Gene therapy (226)
GLP-1 (244)
Government (453)
Grass and pollen (1)
Guidances (28)
Healthcare (1166)
HIV (8)
Huntington's disease (25)
IgA nephropathy (18)
Immunology and inflammation (108)
Immuno-oncology (21)
Indications (7)
Infectious disease (485)
Inflammatory bowel disease (33)
Inflation Reduction Act (3)
Influenza (16)
Intellectual property (36)
Interviews (134)
IPO (1697)
IRA (11)
Job creations (1133)
Job search strategy (660)
Kidney cancer (4)
Labor market (52)
Layoffs (224)
Leadership (23)
Legal (705)
Liver cancer (11)
Longevity (4)
Lung cancer (107)
Lymphoma (42)
Machine learning (15)
Management (22)
Manufacturing (206)
MASH (40)
Medical device (370)
Medtech (371)
Mergers & acquisitions (2964)
Metabolic disorders (248)
Multiple sclerosis (20)
NASH (7)
Neurodegenerative disease (91)
Neuropsychiatric disorders (26)
Neuroscience (475)
NextGen: Class of 2025 (889)
Non-profit (265)
Now hiring (30)
Obesity (151)
Opinion (184)
Ovarian cancer (9)
Pain (19)
Pancreatic cancer (30)
Parkinson's disease (36)
Partnered (12)
Patents (60)
Patient recruitment (52)
Peanut (4)
People (10840)
Pharmaceutical (9)
Phase I (2539)
Phase II (3213)
Phase III (2028)
Pipeline (544)
Policy (108)
Postmarket research (113)
Preclinical (939)
Press Release (53)
Prostate cancer (27)
Psychedelics (24)
Radiopharmaceuticals (50)
Rare diseases (226)
Real estate (1510)
Recruiting (37)
Regulatory (2246)
Reports (15)
Research institute (294)
Resumes & cover letters (150)
Rett syndrome (3)
RNA editing (11)
RSV (14)
Schizophrenia (24)
Series A (104)
Series B (61)
Service/supplier (4)
Sickle cell disease (15)
Special edition (15)
Spinal muscular atrophy (17)
Sponsored (13)
Startups (1224)
Stomach cancer (4)
Supply chain (18)
Tariffs (32)
The Weekly (45)
Vaccines (231)
Venture capital (62)
Weight loss (110)
Women's health (14)
Worklife (8)
Date
Today (23)
Last 7 days (99)
Last 30 days (391)
Last 365 days (4902)
2025 (4682)
2024 (5175)
2023 (5109)
2022 (6198)
2021 (6476)
2020 (5000)
2019 (4066)
2018 (3364)
2017 (4132)
2016 (3770)
2015 (4182)
2014 (5699)
2013 (6396)
2012 (2423)
2011 (2493)
2010 (2091)
Location
Africa (273)
Alabama (9)
Alaska (2)
Arizona (36)
Arkansas (2)
Asia (7263)
Australia (1165)
California (1097)
Canada (472)
China (273)
Colorado (31)
Connecticut (41)
Delaware (51)
Europe (17650)
Florida (181)
Georgia (22)
Hawaii (1)
Idaho (5)
Illinois (40)
India (14)
Indiana (34)
Iowa (3)
Japan (78)
Kansas (10)
Kentucky (5)
Louisiana (4)
Maryland (205)
Massachusetts (984)
Michigan (21)
Minnesota (16)
Mississippi (1)
Missouri (18)
Montana (5)
Nebraska (3)
Nevada (17)
New Hampshire (3)
New Jersey (420)
New Mexico (6)
New York (301)
North Carolina (200)
North Dakota (1)
Northern California (470)
Ohio (37)
Oklahoma (7)
Oregon (5)
Pennsylvania (254)
Rhode Island (13)
South America (294)
South Carolina (3)
Southern California (457)
Tennessee (6)
Texas (143)
United States (4092)
Utah (26)
Virginia (19)
Washington D.C. (17)
Washington State (61)
West Virginia (1)
Wisconsin (16)
81,035 Results for "biotecher".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Special edition
Deep Dive: Chinese Biotech Innovation Can’t Be Stopped
In this deep dive,
BioSpace
investigates China’s rise as a biotech powerhouse.
October 27, 2025
·
3 min read
·
Annalee Armstrong
IN PARTNERSHIP WITH SLONE PARTNERS
How Biotech Funding is Changing Executive Search and Hiring Processes
In this episode presented by Slone Partners, Leslie Loveless, Co-CEO and Managing Partner discusses how hiring and the building of executive teams has responded to the current biotech environment.
November 13, 2025
·
1 min read
·
BioSpace Insights
Regulatory
6 Biotechs With a Shot at the FDA’s Platform Technology Designation
After revoking Sarepta’s award in July and awarding one to Krystal last month, the FDA’s platform technology designation program appears to be back on track. These six biotechs could be on the regulator’s radar.
November 21, 2025
·
9 min read
·
Tristan Manalac
Drug Development
Five Trends That Got Everyone Talking in Pharma and Biotech This Year
In 2025, landmark obesity drug deals, China’s biotech surge, and AI’s deeper integration into pharma operations drove a year of transformation and renewed momentum for life sciences.
November 12, 2025
·
5 min read
·
Jennifer Smith-Parker
IPO
SPACs Line Up To Clear Biotech’s IPO Backlog
Blank check deals dwindled after a crazy 2021. Now, biotechs are starting to turn to special purpose acquisition companies again as an easy route to the public markets.
September 3, 2025
·
6 min read
·
Annalee Armstrong
IN PARTNERSHIP WITH ELEMENT
How Supply Chain Turbulence Is Reshaping Biotech Strategy
In this episode presented by Element Materials Technology, guests Dr. Jihye Jang-Lee and Dr. Khanh Courtney discuss how small biotechs face mounting pressure amid manufacturing uncertainties.
October 23, 2025
·
1 min read
·
BioSpace Insights
Collaboration
Crescent, Kelun-Biotech Swap Therapies in ADC-Bispecific Deal Worth Up To $1.25B
The partnership will focus on Crescent’s PD-1/VEGF inhibitor CR-001 and Kelun-Biotech’s SKB105, both of which the companies plan to push into Phase I/II development for solid tumors early next year.
December 4, 2025
·
2 min read
·
Tristan Manalac
Mergers & Acquisitions
Hectic Markets, Emotions Lead Biotechs To Tack On CVRs
Contingent value rights are rising in a down market, helping to close the gap between buyer and seller expectations in biotech transactions.
September 10, 2025
·
6 min read
·
Annalee Armstrong
Venture capital
Biotech Markets Turn Positive but Experts Say Don’t Call It a Comeback—Yet
M&A is back, the S&P XBI is rising again, a biotech pulled off an IPO and positive data is pulling in investors again. This may just be the industry’s new normal.
October 22, 2025
·
7 min read
·
Annalee Armstrong
Mergers & acquisitions
Tang Capital’s Concentra on Buyout Binge With Plenty of Biotech Fodder
After a slow 2024, the biotech shell company Concentra Biosciences is back, offering to buy four biotechs in the past month and seven so far this year.
August 13, 2025
·
4 min read
·
Annalee Armstrong
1 of 8,104
Next
